{"nct_id":"NCT01702350","title":"A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase Study","status":"TERMINATED","status_verified_date":"2017-06","start_date":"2011-10-21","start_date_type":"ACTUAL","primary_completion_date":"2011-12-08","primary_completion_date_type":"ACTUAL","completion_date":"2011-12-08","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}